Medicare Enrolled
Dr. Evangelos Geraniotis, M.D.
Urology Physician · Hyannis, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Geraniotis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geraniotis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Geraniotis
Dr. Evangelos Geraniotis is an urology physician in Hyannis, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Geraniotis performed 13,207 Medicare services across 4,595 unique beneficiaries.
Between the years covered by Open Payments, Dr. Geraniotis received a total of $7,678 from 39 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Geraniotis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 3% volume in MA
$7,678 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,207
Medicare services
Top 3% in MA for urology physician
4,595
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~660 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
6,983 | $34 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,036 | $93 | $428 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
778 | $66 | $225 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
543 | $34 | $100 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
539 | $34 | $100 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
538 | $34 | $100 |
| Cell examination with selective cellular enhancement A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis. |
284 | $22 | $150 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
272 | $4 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
249 | $8 | $100 |
| Manual urine cell examination A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells. |
225 | $46 | $155 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
192 | $23 | $300 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
180 | $256 | $850 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 156 | $134 | $768 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
147 | $615 | $2,400 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $43 | $150 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
116 | $72 | $400 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
113 | $196 | $650 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $118 | $550 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
58 | $64 | $175 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
52 | $107 | $546 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
49 | $12 | $50 |
| Special tissue stain, multiplex A laboratory procedure using special stains to examine tissue samples. This multiplex technique allows for the analysis of multiple markers on a single slide. |
46 | $30 | $150 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
42 | $141 | $500 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
41 | $186 | $900 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
41 | $48 | $432 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $27 | $100 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
34 | $640 | $3,500 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $139 | $600 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
28 | $2 | $15 |
| Complicated insertion of bladder tube | 24 | $111 | $350 |
| Endoscopic removal of urethral or bladder foreign body A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract. |
24 | $387 | $1,200 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
22 | $30 | $125 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $78 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $143 | $500 |
| Surgery to correct abnormal penis angle A surgical procedure performed to straighten the penis by correcting an abnormal curvature or angle. |
17 | $46 | $348 |
| Insertion of multicomponent inflatable penile implant | 17 | $103 | $400 |
| Insertion of temporary bladder tube | 15 | $37 | $147 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
15 | $562 | $2,000 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $327 | $1,629 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
5.3% medium
94.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,678
Total received (2018-2024)
Avg $1,097/year across 7 years
Top 20% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,266 (55.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,395 (44.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,891
2023
$599
2022
$565
2021
$431
2020
$276
2019
$295
2018
$621
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$4,266
ACCORD HEALTHCARE, INC.
$135
ABBVIE INC.
$114
Olympus America Inc.
$112
Janssen Biotech, Inc.
$53
Ferring Pharmaceuticals Inc.
$40
Tolmar, Inc.
$26
Antares Pharma, Inc.
$26
Teleflex LLC
$24
IMMUNITYBIO, INC.
$22
PFIZER INC.
$20
Telix Pharmaceuticals
$19
Astellas Pharma US Inc
$17
Calyxo, Inc.
$16
Top 3 companies account for 92.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$4,290
Teleflex LLC
$439
PROCEPT BioRobotics Corporation
$432
PFIZER INC.
$243
ABBVIE INC.
$209
Astellas Pharma US Inc
$184
Janssen Biotech, Inc.
$184
AbbVie, Inc.
$141
ACCORD HEALTHCARE, INC.
$135
Antares Pharma, Inc.
$126
Olympus America Inc.
$125
AbbVie Inc.
$108
Janssen Scientific Affairs, LLC
$99
NeoTract Inc.
$90
Allergan, Inc.
$86
Medtronic USA, Inc.
$86
Ferring Pharmaceuticals Inc.
$70
Laborie Medical Technologies Corp.
$54
Agiliti Surgical, Inc.
$53
Tolmar, Inc.
$50
Dendreon Pharmaceuticals LLC
$47
Telix Pharmaceuticals
$40
Myriad Genetic Laboratories, Inc.
$40
Blue Earth Diagnostics Limited
$39
Sun Pharmaceutical Industries Inc.
$38
KARL STORZ Endoscopy-America
$32
Allergan Inc.
$30
ConvaTec Inc.
$25
IMMUNITYBIO, INC.
$22
Beckman Coulter, Inc.
$22
BOSTON SCIENTIFIC CORPORATION
$18
Myovant Sciences Inc.
$18
TOLMAR Pharmaceuticals, Inc.
$17
Coloplast Corp
$16
Calyxo, Inc.
$16
Axonics, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Avadel Specialty Pharmaceuticals, LLC
$14
Ambu Inc.
$12
Top 3 companies account for 67.2% of all-time payments
Associated products mentioned in payments ›
24/26 FR. · ACCESS 2 · ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · Axonics · Axumin · BIPOLAR · BOTOX · CAMCEVI · CUTTING LOOP · CVAC ASPIRATION SYSTEM · ELIGARD · ERLEADA · Erleada · FIRMAGON · GENTLECATH · ILLUCCIX · INTERSTIM · LUPRON DEPOT · LithoVue · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · OPDIVO · ORGOVYX · OTREXUP · Olympus Cystoscopes · PREMARIN · PROLARIS · PROVENGE · Prolaris · REZUM · SOLTIVE · SOLYX · SPEEDICATH · Sonablate · TOVIAZ · UROLIFT · UroLift · UroLift System · XTANDI · XYOSTED · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Urology physicians within 10 mi
13
Per 100K population
5.7
County median income
$94,452
Nearest hospital
CAPE COD HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Geraniotis is a clinical cardiology specialist, with above-average Medicare volume (top 3% in MA), with consulting-driven industry engagement in the top 20% of MA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Geraniotis experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Geraniotis performed 6,983 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Geraniotis receive payments from pharmaceutical companies?
Yes. Dr. Geraniotis received a total of $7,678 from 39 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geraniotis's costs compare to other urology physicians in Hyannis?
Dr. Geraniotis's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geraniotis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Hyannis
Browse urology physicians in Hyannis ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology